See more : JDC Group AG (JDC.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Yatai Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Promimic AB (publ) (PRO.ST) Income Statement Analysis – Financial Results
- Phoenix Township Limited (PHOENIXTN.BO) Income Statement Analysis – Financial Results
- Sulja Bros Building Supplies Ltd. (SLJB) Income Statement Analysis – Financial Results
- BBGI Public Company Limited (BBGI.BK) Income Statement Analysis – Financial Results
- Tribe Capital Growth Corp I (ATVCW) Income Statement Analysis – Financial Results
Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
About Zhejiang Yatai Pharmaceutical Co., Ltd.
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. It offers tablets, capsules, patches, powder injections, and troches. It also provides chemical agents and raw materials, and diagnostic reagents, as well as pharmaceutical research and development outsourcing services. Zhejiang Yatai Pharmaceutical Co., Ltd. was founded in 1989 and is based in Shaoxing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 420.64M | 373.44M | 315.13M | 514.89M | 709.29M | 1.13B | 906.87M | 762.34M | 463.15M | 375.60M | 313.64M | 316.04M | 420.34M | 435.22M | 429.67M | 415.43M | 342.67M | 275.80M |
| Cost of Revenue | 285.65M | 239.83M | 195.76M | 251.29M | 455.36M | 626.30M | 498.59M | 458.38M | 272.79M | 231.62M | 216.63M | 247.77M | 290.12M | 307.76M | 300.75M | 301.79M | 249.92M | 207.33M |
| Gross Profit | 135.00M | 133.61M | 119.38M | 263.59M | 253.93M | 506.09M | 408.27M | 303.97M | 190.35M | 143.98M | 97.01M | 68.27M | 130.22M | 127.47M | 128.92M | 113.64M | 92.75M | 68.47M |
| Gross Profit Ratio | 32.09% | 35.78% | 37.88% | 51.19% | 35.80% | 44.69% | 45.02% | 39.87% | 41.10% | 38.33% | 30.93% | 21.60% | 30.98% | 29.29% | 30.00% | 27.35% | 27.07% | 24.83% |
| Research & Development | 21.79M | 26.14M | 28.62M | 37.35M | 70.10M | 57.21M | 87.10M | 53.99M | 22.83M | 15.91M | 17.50M | 18.68M | 14.45M | 14.93M | 0.00 | 8.52M | 3.05M | 2.64M |
| General & Administrative | 17.27M | 10.44M | 14.14M | 14.21M | 23.15M | 19.42M | -25.63M | -12.24M | 12.09M | 7.20M | 6.16M | 5.94M | 7.67M | 12.85M | 31.39M | 7.42M | 7.95M | 7.55M |
| Selling & Marketing | 58.03M | 72.43M | 140.88M | 205.43M | 197.55M | 156.81M | 128.08M | 66.42M | 58.26M | 45.53M | 44.77M | 51.23M | 45.65M | 30.25M | 30.58M | 27.44M | 20.76M | 17.12M |
| SG&A | 123.14M | 82.87M | 155.01M | 219.65M | 220.70M | 176.22M | 102.45M | 54.17M | 70.35M | 52.73M | 50.92M | 57.18M | 53.32M | 43.10M | 61.97M | 34.85M | 28.71M | 24.66M |
| Other Expenses | 51.89M | 33.77M | 58.72M | 65.21M | 83.69M | 28.00K | -4.72K | 8.65M | 3.15M | 2.78M | -15.47K | -2.69M | 5.43M | 300.68K | -48.10K | 2.47M | -196.88K | 112.23K |
| Operating Expenses | 198.45M | 142.77M | 242.35M | 322.21M | 374.49M | 307.88M | 245.16M | 168.08M | 127.51M | 97.42M | 92.44M | 98.69M | 87.65M | 77.53M | 64.10M | 58.20M | 42.19M | 35.33M |
| Cost & Expenses | 484.10M | 382.60M | 438.11M | 573.50M | 829.85M | 934.18M | 743.75M | 626.46M | 400.30M | 329.04M | 309.06M | 346.46M | 377.77M | 385.29M | 364.85M | 359.99M | 292.11M | 242.66M |
| Interest Income | 14.05M | 11.14M | 10.07M | 9.22M | 8.55M | 3.60M | 7.69M | 3.99M | 4.65M | 3.66M | 4.62M | 8.15M | 6.58M | 3.45M | -0.55 | -0.69 | -0.01 | -0.92 |
| Interest Expense | 47.48M | 52.31M | 56.87M | 68.07M | 57.56M | 15.08M | 1.50M | 23.92M | 3.40M | 35.00K | 751.07K | 3.06M | 2.93M | 4.44M | 6.99M | 8.86M | 6.36M | 8.72M |
| Depreciation & Amortization | 40.40M | 43.77M | 45.63M | 51.34M | 87.01M | 51.48M | 46.32M | 47.44M | 29.35M | 24.97M | 24.27M | 19.78M | 18.52M | 16.63M | 14.10M | 12.69M | 12.41M | 1.40M |
| EBITDA | 76.31M | 25.44M | -121.63M | 147.86M | -1.78B | 308.20M | 285.59M | 172.91M | 99.74M | 73.39M | 31.00M | -8.17M | 71.89M | 69.36M | 78.92M | 68.13M | 62.96M | 34.54M |
| EBITDA Ratio | 18.14% | 6.81% | -27.94% | -3.82% | -167.52% | 21.70% | 22.93% | 24.60% | 21.69% | 20.81% | 10.71% | -1.65% | 17.34% | 16.19% | 18.60% | 16.56% | 16.65% | 11.52% |
| Operating Income | -63.45M | -16.17M | -122.98M | -58.62M | -120.56M | 174.53M | 163.45M | 101.72M | 62.97M | 45.62M | 5.81M | -28.64M | 45.08M | 47.99M | 57.08M | 46.14M | 50.30M | 27.34M |
| Operating Income Ratio | -15.08% | -4.33% | -39.02% | -11.38% | -17.00% | 15.41% | 18.02% | 13.34% | 13.60% | 12.15% | 1.85% | -9.06% | 10.72% | 11.03% | 13.29% | 11.11% | 14.68% | 9.91% |
| Total Other Income/Expenses | 51.89M | -99.32M | -93.04M | -22.69M | -1.80B | 28.00K | -4.73K | -50.87M | 3.02M | 19.23K | -15.47K | -2.69M | 5.36M | 300.68K | -6.75M | -6.13M | -236.38K | 112.23K |
| Income Before Tax | -11.56M | -135.32M | -224.16M | 28.40M | -1.92B | 174.56M | 163.44M | 110.37M | 65.99M | 48.39M | 5.80M | -31.33M | 50.44M | 48.29M | 57.03M | 48.61M | 50.06M | 27.45M |
| Income Before Tax Ratio | -2.75% | -36.24% | -71.13% | 5.52% | -270.91% | 15.41% | 18.02% | 14.48% | 14.25% | 12.88% | 1.85% | -9.91% | 12.00% | 11.10% | 13.27% | 11.70% | 14.61% | 9.95% |
| Income Tax Expense | 313.29K | -2.60M | 4.12M | 1.12M | -312.07K | 22.02M | 23.05M | 11.59M | 9.50M | 7.82M | 319.31K | -5.61M | 6.65M | 6.24M | 8.88M | 7.00M | 10.98M | 6.00M |
| Net Income | -11.88M | -132.72M | -228.28M | 27.27M | -1.92B | 150.95M | 139.50M | 96.80M | 55.50M | 40.57M | 5.48M | -25.72M | 43.79M | 42.05M | 48.15M | 41.61M | 39.09M | 21.46M |
| Net Income Ratio | -2.82% | -35.54% | -72.44% | 5.30% | -270.87% | 13.33% | 15.38% | 12.70% | 11.98% | 10.80% | 1.75% | -8.14% | 10.42% | 9.66% | 11.21% | 10.02% | 11.41% | 7.78% |
| EPS | -0.02 | -0.25 | -0.43 | 0.05 | -3.58 | 0.28 | 0.26 | 0.22 | 0.14 | 0.10 | 0.02 | -0.07 | 0.11 | 0.11 | 0.16 | 0.14 | 0.13 | 0.07 |
| EPS Diluted | -0.02 | -0.25 | -0.43 | 0.05 | -3.58 | 0.28 | 0.26 | 0.22 | 0.14 | 0.10 | 0.02 | -0.07 | 0.11 | 0.11 | 0.16 | 0.14 | 0.13 | 0.07 |
| Weighted Avg Shares Out | 593.85M | 536.69M | 536.62M | 536.56M | 536.50M | 532.78M | 531.98M | 440.00M | 411.11M | 405.68M | 365.35M | 395.65M | 417.09M | 382.24M | 303.18M | 307.55M | 309.06M | 303.98M |
| Weighted Avg Shares Out (Dil) | 593.85M | 536.69M | 536.62M | 536.56M | 536.50M | 539.09M | 536.54M | 440.00M | 411.11M | 405.68M | 365.35M | 395.65M | 417.09M | 382.24M | 303.18M | 307.55M | 309.06M | 303.98M |
No news found for: 002370.SZ
Source: https://incomestatements.info
Category: Stock Reports